iShares JPX-Nikkei 400 ETF
JPXN News Today: Stay Updated with the Latest iShares JPX-Nikkei 400 ETF News in Real Time
Find JPXN news now at Meyka AI. Stay informed with the latest iShares JPX-Nikkei 400 ETF stocks updates, including price news, market analysis, and expert insights.

PHAG.AS €0.00 WisdomTree Silver EURONEXT after hours Mar 2026: outlook
After-hours update on PHAG.AS stock (16 Mar 2026): quote shows €0.00, prior close €67.42, Meyka AI grade and forecast

Pre-market top gainer: 4893.T Noile-Immune Biotech (JPX) jumps 19.88%: heavy volume signals trader interest
4893.T stock jumps 19.88% pre-market to 205.00 JPY on high volume; quick technical and forecast take

BTCUSD Today, March 16: Safe-Haven Bid and ETF Inflows Lift Bitcoin
Bitcoin price in USD jumps near $74,500 as ETF inflows and a safe-haven bid lift BTC. German investors eye Fed rate outlook, USD moves, and key technical levels today.

Volume spike: MVEE.F iShares Europe Min Vol ESG (XETRA) 16 Mar 2026 after hours
After-hours volume spike lifts MVEE.F stock to €6.66 on XETRA; analysis, Meyka grade and €10.12 12-month forecast

Mar 2026 ASOL.SW 21Shares AG Solana ETP (SIX) +7.88% AH: model sees 149.47% upside
ASOL.SW stock jumps 7.88% after hours to CHF48.74; Meyka AI projects CHF121.56 target for 149.47% upside

6613.T QD Laser JPX +30.91% pre-market 17 Mar 2026: heavy volume may extend
Pre-market: 6613.T stock jumps to JPY 1440 on heavy volume; technicals, fundamentals and Meyka AI forecast analysed

Pre-market volume spike: 5610.T Daiwa Heavy Industry JPX 17 Mar 2026, 2,400
Pre-market volume spike for 5610.T stock on JPX; **2,400.00** shares at JPY **1612.00**, early trading signals to watch

INTLOOP (9556.T) down 22.95% pre-market JPX 17 Mar 2026: key levels to watch
Pre-market: **9556.T stock** falls 22.95% to JPY 2011.00 on JPX; heavy volume and oversold technicals, Meyka AI sees potential upside

March 16: Kotak MF Crosses 5% in Park Medi World; Stock Slips, Buy Call
Park Medi World share price slips ~4% to Rs 185 as Kotak Mahindra Mutual Fund stake tops 5%. Nuvama starts coverage with Buy and Rs 280 target. What this means for Indian investors.